Suppression of ICAM-1 in retinal and choroidal endothelial cells by plasmid small-interfering RNAs in vivo

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 1, 2010, Pages 508-515

  Hirano, Yoshio ^a   Sakurai, Eiji ^a   Matsubara, Akihisa ^a   Ogura, Yuichiro ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; PLASMID VECTOR; SMALL INTERFERING RNA; STREPTOZOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CHOROID; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE SEQUENCE; GENE SILENCING; HYDRODYNAMICS BASED TRANSFECTION; IN VIVO GENE TRANSFER; LASER COAGULATION; MALE; MOUSE; NONHUMAN; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; RETINA CELL; UPREGULATION; ANIMAL; C57BL MOUSE; CYTOLOGY; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; GENE EXPRESSION REGULATION; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; METABOLISM; MONOCYTE; PHYSIOLOGY; PLASMID; RETINA; RETINA BLOOD VESSEL; VASCULAR ENDOTHELIUM; VASCULARIZATION;

ANIMALS; CHOROID; DIABETES MELLITUS, EXPERIMENTAL; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; INTERCELLULAR ADHESION MOLECULE-1; LASER COAGULATION; MALE; MICE; MICE, INBRED C57BL; MONOCYTES; PLASMIDS; RETINA; RETINAL VESSELS; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 75749121523     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-3457     Document Type: Article

References (50)

1. Whitcup SM, DeBarge LR, Rosen H, Nussenblatt RB, Chan CC. Monoclonal antibody against CD11b/CD18 inhibits endotoxin-induced uveitis. Invest Ophthalmol Vis Sci. 1993;34:673-681.
2. Joussen AM, Murata T, Tsujikawa A, Kirchhof B, Bursell SE, Adamis AP. Leukocyte-mediated endothelial cell injury and death in the diabetic retina. Am J Pathol. 2001;158:147-152.
3. Joussen AM, Poulaki V, Le ML, et al. A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J. 2004;18:1450-1452.
4. Shen WY, Yu MJ, Barry CJ, Constable IJ, Rakoczy PE. Expression of cell adhesion molecules and vascular endothelial growth factor in experimental choroidal neovascularisation in the rat. Br J Ophthalmol. 1998;82:1063-1071.
5. Sakurai E, Taguchi H, Anand A, et al. Targeted disruption of the CD18 or ICAM-1 gene inhibits choroidal neovascularization. Invest Ophthalmol Vis Sci. 2003;44:2743-2749.
6. van de Stolpe A, van der Saag PT. Intercellular adhesion molecule-1. J Mol Med. 1996;74:13-33.
7. Becker MD, Garman K, Whitcup SM, Planck SR, Rosenbaum JT. Inhibition of leukocyte sticking and infiltration, but not rolling, by antibodies to ICAM-1 and LFA-1 in murine endotoxin-induced uveitis. Invest Ophthalmol Vis Sci. 2001;42:2563-2566.
8. Walker T, Wendel HP, Tetzloff L, Heidenreich O, Ziemer G. Suppression of ICAM-1 in human venous endothelial cells by small interfering RNAs. Eur J Cardiothorac Surg. 2005;28:816-820.
9. Walker T, Wendel HP, Tetzloff L, et al. Inhibition of adhesion molecule expression on human venous endothelial cells by nonviral siRNA transfection. J Cell Mol Med. 2007;11:139-147.
10. Tolentino MJ, Brucker AJ, Fosnot J, et al. Intravitreal injection of vascular endothelial growth factor small interfering RNA inhibits growth and leakage in a nonhuman primate, laser-induced model of choroidal neovascularization. Retina. 2004;24:132-138.
11. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 2001;24:494-498.
12. Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science. 2002;296:550-553.
13. Kim DH, Rossi JJ. Strategies for silencing human diseases using RNA interference. Nat Rev Genet. 2007;8:173-184.
14. Bitko V, Musiyenko A, Shulyayeva O, Barik S. Inhibition of respiratory viruses by nasally administered siRNA. Nat Med. 2005;11:50-55.
15. Liu F, Song Y, Liu D. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther. 1999;6:1258-1266.
16. Zhang G, Budker V, Wolff JA. High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. Hum Gene Ther. 1999;10:1735-1737.
17. Zhang G, Song YK, Liu D. Long-term expression of human alpha1-antitrypsin gene in mouse liver achieved by intravenous administration of plasmid DNA using a hydrodynamics-based procedure. Gene Ther. 2000;7:1344-1349.
18. Tsuyama Y, Kitajima M, Miyano-Kurosaki N, Takaku H. Anti-tumor effects of naked plasmid DNA using a hydrodynamics-based procedure. Nucleic Acids Symp Ser (Oxf). 2004;48:239-240.
19. Kitajima M, Tsuyama Y, Miyano-Kurosaki N, Takaku H. Anti-tumor effect of intravenous TNFalpha gene delivery naked plasmid DNA using a hydrodynamics-based procedure. Nucleosides Nucleotides Nucleic Acids. 2005;24:647-650.
20. Miyamoto K, Khosrof S, Bursell SE, et al. Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1(ICAM-1). Am J Pathol. 2000;156:1733-1739.
21. Al-Mutawa SA, Hegab SM. Behçet's disease. Clin Exp Med. 2004;4:103-131.
22. McLeod DS, Lefer DJ, Merges C, Lutty GA. Enhanced expression of intracellular adhesion molecule-1 and p-selectin in the diabetic human retina and choroid. Am J Pathol. 1995;147:642-653.
23. Yeh DC, Bula DV, Miller JW, Gragoudas ES, Arroyo JG. Expression of leukocyte adhesion molecules in human subfoveal choroidal neovascular membranes treated with and without photodynamic therapy. Invest Ophthalmol Vis Sci. 2004;45:2368-2373.
24. Mullins RF, Skeie JM, Malone EA, Kuehn MH. Macular and peripheral distribution of ICAM-1 in the human choriocapillaris and retina. Mol Vis. 2006;12:224-235.
25. McCaffrey AP, Meuse L, Ince N, et al. RNA interference in adult mice. Nature. 2002;418:38-39.
26. Song E, Lee SK, Wang J, et al. RNA interference targeting Fas protects mice from fulminant hepatitis. Nat Med. 2003;9:347-351.
27. Robbins PD, Tahara H, Ghivizzani SC. Viral vectors for gene therapy. Trends Biotechnol. 1998;16:35-40.
28. Miller AD, Miller DG, Garcia JV, Lynch CM. Use of retroviral vectors for gene transfer and expression. Meth Enzymol. 1993;217:581-599.
29. Gilboa E, Eglitis MA, Kantoff PW, Anderson WF. Transfer and expression of cloned genes using retroviral vectors. BioTechniques. 1986;4:504-512.
30. Berkner KL. Expression of heterologous sequences in adenoviral vectors. Curr Top Microbiol Immunol. 1992;58:39-66.
31. Kozarsky KF, Wilson JM. Gene therapy: adenovirus vectors. Curr Opin Gen Dev. 1993;3:499-503.
32. Muzycka N. Use of adeno-associated virus as a general transduction vector for mammalian cells. Curr Top Microbiol Immunol. 1992;158:97-129.
33. Carter BJ. Adeno-associated virus vectors. Curr Opin Biotechnol. 1992;3:533-539.
34. Fink DJ, DeLuca NA, Goins WF, Glorioso JC. Gene transfer to neurons using HSV-based vectors. Annu Rev Neurosci. 1996;19:245-287.
35. Naldini L, Blömer U, Gallay P, et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science. 1996;272:263-267.
36. Margolskee RF. Epstein-Barr virus based expression vectors. Curr Top Microbiol Immunol. 1992;158:67-95.
37. Moss B. Vaccinia virus vectors. BioTechniques. 1992;20:345-362.
38. Yang Y, Li Q, Ertl HC, Wilson JM. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J Virol. 1995;69:12004-12015.
39. Barr D, Tubb J, Ferguson D, et al. Strain-related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: comparisons between immunocompetent and immunodeficient inbred strains. Gene Ther. 1995;2:151-155.
40. Herweijier H, Wolff JA. Progress and prospects: naked DNA gene transfer and therapy. Gene Ther. 2003;10:453-458.
41. Ehrhardt A, Peng PD, Xu H, et al. Optimization of cis-acting elements for gene expression from nonviral vectors in vivo. Hum Gene Ther. 2003;14:215-225.
42. Cornetta K, Morgan RA, Anderson WF. Safety issues related to retroviral-mediated gene transfer in humans. Hum Gene Ther. 1991;2:5-14.
43. Gunter KC, Khan AS, Noguchi PD. The safety of retroviral vectors. Hum Gene Ther. 1993;4:643-645.
44. Chang J, Sigal LJ, Lerro A, et al. Replication of the human hepatitis delta virus genome is initiated in mouse hepatocytes following intravenous injection of naked DNA or RNA sequences. J Virol. 2001;75:3469-3473.
45. Kobayashi N, Nishikawa M, Takakura Y. The hydrodynamics-based procedure for controlling the pharmacokinetics of gene medicines at whole body, organ and cellular levels. Adv Drug Deliv Rev. 2005;57:713-731.
46. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhaboditis elegans. Nature. 1998;391:806-811.
47. Sharp PA. RNA interference-2001. Genes Dev. 2001;15:485-490.
48. Chuang CF, Meyerowitz EM. Specific and heritable genetic interference by double-stranded RNA in Arabidopsis thaliana. Proc Natl Acad Sci U S A. 2000;97:4985-4990.
49. Misquitta L, Paterson BM. Targeted disruption of gene function in Drosophila by RNA interference (RNA-i): a role for nautilus in embryonic somatic muscle formation. Proc Natl Acad Sci U S A. 1999;96:1451-1456.
50. Tuschl T, Zamore PD, Lehmann R, Bartel DP, Sharp PA. Targeted mRNA degradation by double-stranded RNA in vitro. Genes Dev. 1999;13:3191-3197.